Sonoma Orthopedic Products received $12 million in funding from First Analysis, according to a Reuters PE Hub report.
Sonoma Orthopedic Products focuses on developing and manufacturing orthopedic implants for the wrist, ankle and collarbone. The financing round is intended to allow the company to receive clearance from the U.S. Food and Drug Administration for its new ankle implant as well as launch it and scale it commercially.
First Analysis is a private growth-equity investor.
More articles on devices:
VEXIM's Masterflow Injection System for orthopedic cement gains FDA clearance
RTI Surgical's EVP of Administration Thomas Rose to retire: 3 quick facts
EOS imaging's hipEOS receives FDA approval